The impact of HIV-1 on the malaria parasite biomass in adults in sub-Saharan Africa contributes to the emergence of antimalarial drug resistance

Malaria Journal

Volumn 7, Issue , 2008, Pages

  Van Geertruyden, Jean Pierre ^a   Menten, Joris ^a   Colebunders, Robert ^b   Korenromp, Eline ^c,d   D'Alessandro, Umberto ^a  

^a INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d TUBERCULOSIS AND MALARIA   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT;

ADOLESCENT; ADULT; AFRICA; ANTIBIOTIC RESISTANCE; ARTICLE; BIOMASS; CENTRAL AFRICAN REPUBLIC; CHILD; CIRCULATION; CONFIDENCE INTERVAL; ENDEMIC DISEASE; GROUPS BY AGE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALARIA; MALAWI; MATHEMATICAL MODEL; MIXED INFECTION; MONTE CARLO METHOD; MOZAMBIQUE; MULTIVARIATE ANALYSIS; NEWBORN; PARASITE TRANSMISSION; RURAL AREA; SENSITIVITY ANALYSIS; UNIVARIATE ANALYSIS; URBAN AREA; ZAMBIA; AFRICA SOUTH OF THE SAHARA; AIDS RELATED COMPLEX; ANIMAL; CD4 LYMPHOCYTE COUNT; DRUG EFFECT; DRUG RESISTANCE; GROWTH, DEVELOPMENT AND AGING; PARASITOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD;

ADOLESCENT; AFRICA SOUTH OF THE SAHARA; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANIMALS; ANTIMALARIALS; BIOMASS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; HIV INFECTIONS; HIV-1; HUMANS; MALARIA; PLASMODIUM FALCIPARUM;

EID: 49849092995     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-7-134     Document Type: Article

References (52)

1. Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. J Whitworth D Morgan M Quigley A Smith B Mayanja H Eotu N Omoding M Okongo S Malamba A Ojwiya, Lancet 2000 356 1051 1056 10.1016/S0140-6736(00)02727-6 11009139
2. HIV-1 and parasitic infections in rural Tanzania. C Atzori A Bruno G Chichino C Cevini AM Bernuzzi S Gatti G Comolli M Scaglia, Ann Trop Med Parasitol 1993 87 585 593 8122920
3. Impairment of a pregnant woman's acquired ability to limit Plasmodium falciparum by infection with human immunodeficiency virus type-1. RW Steketee JJ Wirima PB Bloland B Chilima JH Mermin L Chitsulo JG Breman, Am J Trop Med Hyg 1996 55 42 49 8702036
4. Increased prevalence of malaria in HIV-infected pregnant women and its implications for malaria control. FH Verhoeff BJ Brabin CA Hart L Chimsuku P Kazembe RL Broadhead, Trop Med Int Health 1999 4 5 12 10.1046/j.1365-3156.1999. 00349.x 10203167
5. Interactions between HIV and malaria in non-pregnant adults: evidence and implications. K Hewitt R Steketee V Mwapasa J Whitworth N French, AIDS 2006 20 1993 2004 10.1097/01.aids.0000247572.95880.92 17053345
6. Malaria attributable to the HIV-1 epidemic, sub-Saharan Africa. EL Korenromp BG Williams SJ de Vlas E Gouws CF Gilks PD Ghys BL Nahlen, Emerg Infect Dis 2005 11 1410 1419 16229771
7. Dual infection with HIV and malaria fuels the spread of both diseases in sub-Saharan Africa. LJ Abu-Raddad P Patnaik JG Kublin, Science 2006 314 1603 1606 10.1126/science.1132338 17158329
8. Malaria disaster in Africa. K Marsh, Lancet 1998 352 924 10.1016/S0140-6736(05)61510-3 9752813
9. Averting a malaria disaster. NJ White F Nosten S Looareesuwan WM Watkins K Marsh RW Snow G Kokwaro J Ouma TT Hien ME Molyneux TE Taylor CI Newbold TK Ruebush M Danis BM Greenwood RM Anderson P Olliaro, Lancet 1999 353 1965 1967 10.1016/S0140-6736(98)07367-X 10371589
10. The public health burden of Plasmodium falciparum malaria in Africa: deriving the numbers. Working Paper 11, Disease Control Priorities Project. S RW C MH Newton CRJC S RW, The Disease Control Priorities Project (DCPP) Working Paper Series Maryland, Fogarty International Center, National Institutes of Health;, Bethesda, 2003
11. Short report: entomologic inoculation rates and Plasmodium falciparum malaria prevalence in Africa. JC Beier GF Killeen JI Githure, Am J Trop Med Hyg 1999 61 109 113 10432066
12. World population prospects - the 2004 revision population database. U Nations, New York, United Nations Population Division 2002
13. Symptomatology: general considerations and falciparum malaria. SF Kitchen, Malariology Philadelphia, WB Saunders, Boyd MF, 1949 996 1017
14. LOG-normal distributions across the sciences: keys and clues. L E S WA A M, Bioscience 2001 51 341 352 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2
15. Why do some African children develop severe malaria? B Greenwood K Marsh R Snow, Parasitol Today 1991 7 277 281 10.1016/0169-4758(91)90096-7 15463389
16. HIV infection as a cofactor for severe falciparum malaria in adults living in a region of unstable malaria transmission in South Africa. K Grimwade N French DD Mbatha DD Zungu M Dedicoat CF Gilks, AIDS 2004 18 547 554 10.1097/00002030-200402200-00023 15090809
17. Plasmodium Falciparum malaria and perinatally acquired human immunodeficiency virus type 1 infection in Kinshasa, Zaire. A prospective, longitudinal cohort study of 587 children. AE Greenberg W Nsa RW Ryder M Medi M Nzeza N Kitadi M Baangi N Malanda F Davachi SE Hassig, N Engl J Med 1991 325 105 109 2052043
18. Effects of malaria infection in human immunodeficiency virus type 1-infected Ugandan children. I Kalyesubula P Musoke-Mudido L Marum D Bagenda E Aceng C Ndugwa K Olness, Pediatr Infect Dis J 1997 16 876 881 10.1097/00006454-199709000-00011 9306483
19. Increased severe anemia in HIV-1-exposed and HIV-1-positive infants and children during acute malaria. RO Otieno C Ouma JM Ong'echa CC Keller T Were EN Waindi MG Michaels RD Day JM Vulule DJ Perkins, AIDS 2006 20 275 280 10.1097/01.aids.0000200533.56490.b7 16511422
20. An epidemiologic model of severe morbidity and mortality caused by Plasmodium falciparum. A Ross N Maire L Molineaux T Smith, Am J Trop Med Hyg 2006 75 63 73 16931817
21. Increasing rates of malarial fever with deteriorating immune status in HIV-1-infected Ugandan adults. N French J Nakiyingi E Lugada C Watera JA Whitworth CF Gilks, AIDS 2001 15 899 906 10.1097/00002030-200105040-00010 11399962
22. Impact of HIV-associated immunosuppression on malaria infection and disease in Malawi. MK Laufer JJ van Oosterhout PC Thesing F Thumba EE Zijlstra SM Graham TE Taylor CV Plowe, J Infect Dis 2006 193 872 878 10.1086/500245 16479522
23. Effects of HIV-1 serostatus, HIV-1 RNA concentration, and CD4 cell count on the incidence of malaria infection in a cohort of adults in rural Malawi. P Patnaik CS Jere WC Miller IF Hoffman J Wirima R Pendame SR Meshnick TE Taylor ME Molyneux JG Kublin, J Infect Dis 2005 192 984 991 10.1086/432730 16107950
24. CD4 T-Cell Count and HIV-1 Infection in Adults With Uncomplicated Malaria. JP van Geertruyden M Mulenga W Kasongo K Polman R Colebunders L Kestens U D'Alessandro, J Acquir Immune Defic Syndr 2006 43 363 367 10.1097/01.qai.0000243125.98024.da 17079994
25. Human immunodeficiency virus type 1 infection in patients with severe falciparum malaria in urban India. AA Khasnis DR Karnad, J Postgrad Med 2003 49 114 117 12867684
26. Increased prevalence of severe malaria in HIV-infected adults in South Africa. C Cohen A Karstaedt J Frean J Thomas N Govender E Prentice L Dini J Galpin H Crewe-Brown, Clin Infect Dis 2005 41 1631 1637 10.1086/498023 16267737
27. UNAIDS. Report on the global HIV/AIDS epidemic. Geneva, Joint United Nations Programme on HIV/AIDS (UNAIDS) Report No.: 2006
28. HIV prevalence and trends in sub-Saharan Africa: no decline and large subregional differences. E Asamoah-Odei JM Garcia Calleja JT Boerma, Lancet 2004 364 35 40 10.1016/S0140-6736(04)16587-2 15234854
29. AM Law WD Kelton, Simulation modeling and analysis MacGraw-Hill, 400 p. 1982
30. RDC Team, A Language and Environment for Statistical Computing. Vienna, Austria, R Foundation for Statistical Computing 2005 http://www.r-project.org
31. The de novo selection of drug-resistant malaria parasites. NJ White W Pongtavornpinyo, Proc Biol Sci 2003 270 545 554 12641911 10.1098/rspb.2002.2241
32. Estimating mortality, morbidity and disability due to malaria among Africa's non-pregnant population. RW Snow M Craig U Deichmann K Marsh, Bull World Health Organ 1999 77 624 640 10516785
33. Antimalarial drug resistance. NJ White, J Clin Invest 2004 113 1084 1092 15085184
34. Complex dynamics and stability of resistance to antimalarial drugs. IM Hastings, Parasitology 2006 132 615 624 10.1017/S0031182005009790 16426485
35. Combination therapy for malaria: the way forward? F Nosten P Brasseur, Drugs 2002 62 1315 1329 10.2165/00003495-200262090-00003 12076181
36. Delayed clearance of Plasmodium falciparum in patients with human immunodeficiency virus co-infection treated with artemisinin. Y Birku E Mekonnen A Bjorkman D Wolday, Ethiop Med J 2002 40 Suppl 1 17 26 12802828
37. HIV-1 immune suppression and antimalarial treatment outcome in Zambian adults with uncomplicated malaria. JP van Geertruyden M Mulenga L Mwananyanda V Chalwe F Moerman R Chilengi W Kasongo C Van Overmeir JC Dujardin R Colebunders L Kestens U D'Alessandro, J Infect Dis 2006 194 917 925 10.1086/507310 16960779
38. HIV Immunosuppression and Antimalarial Efficacy: Sulfadoxine- Pyrimethamine for the Treatment of Uncomplicated Malaria in HIV-Infected Adults in Siaya, Kenya. SN Shah EE Smith CO Obonyo KC Kain PB Bloland L Slutsker MJ Hamel, J Infect Dis 2006 194 1519 1528 10.1086/508892 17083036
39. Modelling a predictable disaster: the rise and spread of drug-resistantmalaria. IM Hastings U D'Alessandro, Parasitol Today 2000 16 340 347 10.1016/S0169-4758(00)01707-5 10900482
40. History, dynamics, and public health importance of malaria parasite resistance. AO Talisuna P Bloland U D'Alessandro, Clin Microbiol Rev 2004 17 235 254 14726463 10.1128/CMR.17.1.235-254.2004
41. World Malaria Report 2005. WH Organization UNC Fund, Geneva, Switzerland: World Health Organization 2005 http://rbm.who.int/wmr2005 (accessed Sept 9, 2007)
42. Effect of co-trimoxazole prophylaxis, antiretroviral therapy, and insecticide-treated bednets on the frequency of malaria in HIV-1-infected adults in Uganda: a prospective cohort study. J Mermin JP Ekwaru CA Liechty W Were R Downing R Ransom P Weidle J Lule A Coutinho P Solberg, Lancet 2006 367 1256 1261 10.1016/S0140-6736(06)68541-3 16631881
43. Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members. J Mermin J Lule JP Ekwaru R Downing P Hughes R Bunnell S Malamba R Ransom F Kaharuza A Coutinho A Kigozi R Quick, AIDS 2005 19 1035 1042 15958834
44. Preventing childhood malaria in Africa by protecting adults from mosquitoes with insecticide-treated nets. GF Killeen TA Smith HM Ferguson H Mshinda S Abdulla C Lengeler SP Kachur, PLoS Med 2007 4 e229 17608562 10.1371/journal.pmed.0040229
45. Trends and risk factors for HIV-1 seropositivity among outpatient children, Kinshasa, Zaire. N Shaffer K Hedberg F Davachi B Lyamba JG Breman OS Masisa F Behets A Hightower P Nguyen-Dinh, AIDS 1990 4 1231 1236 10.1097/00002030-199012000-00008 2088400
46. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. J Mermin J Lule JP Ekwaru S Malamba R Downing R Ransom F Kaharuza D Culver F Kizito R Bunnell A Kigozi D Nakanjako W Wafula R Quick, Lancet 2004 364 1428 1434 10.1016/S0140-6736(04)17225-5 15488218
47. Effect of HIV-1 infection on antimalarial treatment outcomes in Uganda: a population-based study. MR Kamya AF Gasasira A Yeka N Bakyaita SL Nsobya D Francis PJ Rosenthal G Dorsey D Havlir, J Infect Dis 2006 193 9 15 10.1086/498577 16323126
48. Childhood malaria parasitaemia and human immunodeficiency virus infection in Malawi. TE Taha JK Canner GA Dallabetta JD Chiphangwi G Liomba AM Wangel AJ Saah PG Miotti, Trans R Soc Trop Med Hyg 1994 88 164 165 10.1016/0035-9203(94) 90277-1 8036659
49. Incidence of malaria and efficacy of oral quinine in patients recently infected with human immunodeficiency virus in Kinshasa, Zaire. R Colebunders Y Bahwe W Nekwei R Ryder J Perriens K Nsimba A Turner H Francis I Lebughe SP van der, J Infect 1990 21 167 173 10.1016/0163-4453(90)91701-E 2230175
50. The clinical and parasitological presentation of Plasmodium falciparum malaria in Uganda is unaffected by HIV-1 infection. O Muller R Moser, Trans R Soc Trop Med Hyg 1990 84 336 338 10.1016/0035-9203(90)90306-Y 2260160
51. Relation between falciparum malaria and HIV seropositivity in Ndola, Zambia. OO Simooya RM Mwendapole S Siziya AF Fleming, BMJ 1988 297 30 31 3044486
52. Childhood malaria in a region of unstable transmission and high human immunodeficiency virus prevalence. K Grimwade N French DD Mbatha DD Zungu M Dedicoat CF Gilks, Pediatr Infect Dis J 2003 22 1057 1063 10.1097/01.inf. 0000101188.95433.60 14688565